American Society For Gastrointestinal Endoscopy

Program

7:00 am Registration and Continental Breakfast

7:25-7:30 Introductory remarks

SESSION I

Session Chair: Keith Naunheim

7:30-8:15 Minimally invasive esophagectomy vs open esophagectomy:
Discussants: Mark K.Ferguson and James D.Luketich
Moderator: Keith Naunheim

8:15-8:45 State-of-the-art lecture:Downstaging liver
metastatic lesions from colorectal cancer with chemotherapy
followed by surgery
Speaker: Henri Bismuth
Speaker introduction byTheresa Cavins

8:45-9:30 Surgery for colorectal cancers: laparoscopic colectomy vs open colectomy
Discussants: Anthony Senagore and Richard Billingham
Moderator: Larry Mendelow

9:30-9:45 Coffee Break
Session Co-Chairs: Banke Agarwal and Giuseppe Aliperti

SESSION II

9:45-11:45 Advances in endoscopic techniques for diagnosis,staging and treatment of gastrointestinal malignancies

Panelists:

  1. Michael Kochman
  2. Gary Falk
  3. Kenneth Wang
  4. Michael Wallace
  5. William Brugge
  6. John Baillie

Points of discussion:

  • How can the endoscopist participate in management of patients with suspected or proven GI cancers
    • Diagnostic techniques/tests
    • Staging procedures
    • Endoscopic therapy
    • Endoscopic palliation
  • What are the new advances in endoscopic technology for diagnosis,staging and treatment of GI cancers
    • What additional benefit do these advances offer
    • Who are the patients who would potentially benefit
  • What new endoscopic advances are in the horizon

11:45-12:45 Lunch

SESSION III

Session Co-Chairs: Gary Ratkin and David Cort

12:45-2:45 Colorectal cancer case studies: approach and controversies in screening, diagnosis,management and follow-up

Panelists:

  1. Ralf Kiesslich
  2. Juan Nogueras
  3. Stanley Hamilton
  4. Richard Goldberg
  5. Randall Burt
  6. Bruce Minsky

Points of discussion:

  • Screening
    • Who should be screened
    • High-risk genetic assessment
    • How should screening be done
  • Diagnosis/staging
    • Endoscopic techniques
    • Pathology/genetics
    • Staging work-up
  • Management
    • Role of surgery,chemotherapy and radiation
    • Pre-operative vs post-operative chemoradiation
  • Follow-up
    • How often should the patient be seen
    • Where and how to look for recurrent cancer
    • Molecular markers for follow up

2:45-3:00 Coffee Break

SESSION IV

Session Co-Chairs: John Visconti and Edward Lin

3:00-4:00 Diagnostic evaluation and management of gastrointestinal stromal tumors (GIST):

Panelists:

  1. Robert Benjamin
  2. Michael Kochman
  3. Peter Pisters

Points of discussion:

  • When to suspect and how to diagnose GIST
  • Do we treat all patients with GIST irrespective of size
  • Role of surgery and Gleevac
  • Second line therapies for GIST
  • Follow up of patients with GIST

4:00-5:00 Diagnostic evaluation and management of gastrointestinal neuroendocrine tumors

Panelists:

  1. Robert Gagel
  2. Michael Wallace
  3. Allan Siperstein

Points of discussion:

  • When to suspect GI neuroendocrine tumors
  • What are the diagnostic tests available
  • Diagnostic work-up in a particular patient
  • When to suspect hereditary/genetic disorders
  • Role of surgery in management of NE tumors
  • Role of chemotherapy in management of NE tumors
  • Follow-up of patients with NE tumors